Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
20 Oct 2017
UCB First Nine Months Interim Report 2017: Strong 9 months performance allows for increase of 2017 financial outlook
Read More
19 Oct 2017
By the time you finish reading this headline another person will have suffered a fragility fracture due to osteoporosis1
Read More
13 Oct 2017
Transparency notification The Capital Group Companies
Read More
21 Sep 2017
UCB’s anti-epileptic drug VIMPAT® (lacosamide) receives EU approval for paediatric use
Read More
15 Sep 2017
New indication for BRIVIACT® (brivaracetam): UCB’s newest antiepileptic drug approved by FDA as monotherapy treatment of partial-onset seizures in adults
Read More
14 Sep 2017
New CIMZIA® (certolizumab pegol) Findings Presented at European Academy of Dermatology and Venereology (EADV) Congress
Read More
11 Sep 2017
EVENITYTM (romosozumab) ARCH Study Results Published in the New England Journal of Medicine
Read More
7 Sep 2017
UCB highlights latest EVENITY™ (romosozumab) research at the American Society for Bone and Mineral Research Annual Meeting
Read More
23 Aug 2017
Transparency notification Wellington
Read More
2 Aug 2017
Transparency notification The Capital Group Companies
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
29
Page
30
Page
31
Page
32
Current page
33
Page
34
Page
35
Page
36
Page
37
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss